Neuropathy is affecting about 25 million Americans today. The common solutions are medications that simply mask the problem, ...

Dr. Evan Norum, DC, BCN, from Advantage Neuropathy, joins us on The Morning Blend to discuss the types of neuropathies, ...

The diabetic neuropathy market is poised for growth driven by clinical evidence, patient-centric care, digital health models, and innovative pharmacologic options. Key opportunities include enhancing ...

When you look in the mirror and notice thinning hair, or step on the scale and see numbers that don't reflect how you want to feel, it's easy to treat ...

DiaCardia, a novel artificial intelligence model that can accurately identify individuals with prediabetes using either ...

Treatment for stage 3 myeloma is typically divided into phases. The goal is to achieve a deep remission, meaning the cancer ...

Cancer treatments take a huge toll on patients, as you can imagine. One lawmaker is hoping to ease that burden, though, with ...

Starting a new type 2 diabetes treatment can feel overwhelming, but asking the right questions helps you manage it better.

Which of the statements about the recent guideline for evaluating and managing peripheral nervous system manifestations of Sjögren disease are correct?

Treatments for are allergic fungal rhinosinusitis, bipolar I disorder, Hunter syndrome, Leber hereditary optic neuropathy, ovarian cancer, and schizophrenia under review.

Genetic disorders occur due to alterations in the primary genetic material, deoxyribonucleic acid (DNA), of an organism.

Lower risk for foot disease driven by lower risk for neuropathy for new users of SGLT-2 inhibitors versus GLP-1 receptor agonists.